Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -232,100 | -170,800 | -54,700 | -112,000 | -69,700 |
| Depreciation Amortization | 46,800 | 32,700 | 19,400 | 69,600 | 49,700 |
| Income taxes - deferred | -1,700 | -700 | 100 | -30,800 | -22,000 |
| Accounts receivable | -13,700 | -10,100 | -17,500 | -10,300 | -12,800 |
| Accounts payable and accrued liabilities | 2,200 | 10,700 | 7,600 | -3,500 | -1,100 |
| Other Working Capital | 68,300 | 58,500 | -24,300 | -101,500 | -98,000 |
| Other Operating Activity | 74,000 | 45,600 | 36,200 | 82,200 | 54,900 |
| Operating Cash Flow | $-56,200 | $-34,100 | $-33,200 | $-106,300 | $-99,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -53,200 | -42,300 | -23,500 | -45,300 | -30,700 |
| Net Acquisitions | N/A | N/A | N/A | -57,200 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -103,200 | -98,800 |
| Sale Of Investment | 103,700 | 88,700 | 58,100 | 128,200 | 87,600 |
| Purchase Sale Intangibles | -6,600 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -6,600 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $43,900 | $46,400 | $34,600 | $-77,500 | $-41,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,000 | 40,000 | 0 | N/A | 0 |
| Debt Repayment | -100 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 0 | 0 | N/A | 6,300 | 3,900 |
| Other Financing Activity | -8,900 | -6,500 | -4,900 | -14,300 | -9,800 |
| Financing Cash Flow | $31,000 | $33,500 | $-4,900 | $-8,000 | $-5,900 |
| Exchange Rate Effect | -100 | 500 | 200 | -600 | -1,300 |
| Beginning Cash Position | 66,400 | 66,400 | 66,400 | 258,800 | 258,800 |
| End Cash Position | 85,000 | 112,700 | 63,100 | 66,400 | 110,700 |
| Net Cash Flow | $18,600 | $46,300 | $-3,300 | $-192,400 | $-148,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,200 | -34,100 | -33,200 | -106,300 | -99,000 |
| Capital Expenditure | -53,200 | -42,300 | -23,500 | -45,300 | -30,700 |
| Free Cash Flow | -109,400 | -76,400 | -56,700 | -151,600 | -129,700 |